Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Renjian Pharmaceutical is a Chinese pharmaceutical company founded in 1988 and headquartered in Ningbo, Zhejiang Province. The company specializes in the development and manufacture of active pharmaceutical ingredients (APIs), chemical intermediates, and finished formulations, with a strong focus on biochemical and hormonal products. Its core portfolio includes human chorionic gonadotropin (HCG), menotrophins (HMG), heparin sodium, and oxytocin, which are used in reproductive health, endocrinology, and hematology. Renjian operates as a National High-Tech Enterprise with a significant global presence, exporting over 90% of its products to markets in Europe, America, and Asia. The company also provides CDMO and CMO services, leveraging its large-scale manufacturing facilities and R&D center.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Renjian Pharmaceutical.